Comparative Pharmacology
Head-to-head clinical analysis: DIALYTE CONCENTRATE W DEXTROSE 50 IN PLASTIC CONTAINER versus DIALYTE LM DEXTROSE 2 5 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DIALYTE CONCENTRATE W DEXTROSE 50 IN PLASTIC CONTAINER versus DIALYTE LM DEXTROSE 2 5 IN PLASTIC CONTAINER.
DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER vs DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Provides dextrose as a caloric source and electrolyte replacement in peritoneal dialysis. Dextrose is metabolized to carbon dioxide and water, generating ATP. The high osmolality of the solution promotes ultrafiltration of fluid across the peritoneal membrane, facilitating removal of uremic toxins and excess fluid.
Dialysis solution containing dextrose and electrolytes; dextrose provides osmotic gradient for ultrafiltration and caloric supplementation, while electrolytes maintain acid-base and electrolyte balance in peritoneal dialysis.
Not applicable; dialysate concentrate is used in hemodialysis machines, not administered directly to patients. Dextrose concentration in final dialysate is typically 1.5-2.5 g/dL depending on prescription.
Intravenous infusion, 500-2000 mL per day as maintenance fluid; rate adjusted based on clinical status, typically 1-2 mL/kg/hour in adults.
None Documented
None Documented
Not applicable as a fixed half-life; glucose has a plasma elimination half-life of approximately 15-20 minutes, but this is concentration-dependent. Dialysis solutions are not administered as a single intravenous dose; the components are continuously infused.
Terminal half-life: 2.5–3.5 hours. Clinically, this allows for rapid clearance; accumulation may occur in renal impairment.
Renal excretion of glucose and electrolytes; glucose is completely reabsorbed or metabolized, while electrolytes are excreted proportionally to serum levels and renal function. 100% renal elimination of administered electrolytes.
Renal: >95% as unchanged drug and metabolites. Biliary/fecal: <5%.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution